# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
S&P 500 constituent Stryker Corp. is acquiring Inari Medical in a deal expected to be completed soon, pending final closing...
These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in ...
BTIG analyst Marie Thibault downgrades Inari Medical (NASDAQ:NARI) from Buy to Neutral.
Wells Fargo analyst Larry Biegelsen downgrades Inari Medical (NASDAQ:NARI) from Overweight to Equal-Weight and raises the pr...
William Blair analyst Margaret Andrew downgrades Inari Medical (NASDAQ:NARI) from Outperform to Market Perform.
Piper Sandler analyst Adam Maeder maintains Inari Medical (NASDAQ:NARI) with a Neutral and raises the price target from $52 ...